Suven Life Sciences Limited (SUVEN.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 30B |
| Enterprise Value | 26.8B |
| P/E Ratio | -24.4 |
| PEG Ratio | 0.49 |
| Price/Sales Ratio | 919.9 |
| Price/Book Ratio | 16.99 |
| Enterprise/Revenue | 883.5 |
| Enterprise/EBITDA | -22.06 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -39.99 |
| Operating Margin | -42.28 |
AD
Management Effectiveness
| Return On Assets | -0.56 |
| Return On Equity | -1.12 |
Income Statement
| Revenue | 71.15M |
| Revenue/Share | 0.31 |
| Gross Profit | -419.28M |
| EBITDA | -2.71B |
| Net Income | -2.76B |
| Diluted EPS | -12.13 |
Balance Sheet
| Total Cash | 5.18B |
| Total Cash/Share | 18.34 |
| Total Debt | 166.94M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 17.69 |
| Book Value Per Share | 20.93 |
Price History
| 52-Week Change | 60.6 |
| 52-Week High | 403.35 |
| 52-Week Low | 124.11 |
| Moving Average 50 Days | 341.57 |
| Moving Average 200 Days | 226.29 |
Statistics
| Average Volume | 1.29M |
| Shares Outstanding | 228.04M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 217:200 |
| Last Split Date | October 17, 2022 |
AD
